Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

997157

	registered interest
	date	29/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many hospital trusts (a) collect and (b) submit data on the number of people diagnosed with secondary breast cancer to the cancer outcomes and services data set.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	184978
	answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>140 hospital trusts submitted data for 2016 secondary breast cancer diagnoses through the Cancer Outcomes and Services Dataset or Cancer Waiting Times data collection mechanisms. The total number submitted was 11,608, which is an increase on 2014 and 2015. This is accepted as being significantly below the estimated number of secondary breast cancers.</p><p> </p><p>The National Cancer Registration and Analysis Service (NCRAS) has published a number of guidance documents including flowcharts and clearer data definitions, providing specific advice on how to record cancer patients who are on a non-primary pathway. NCRAS is visiting trusts to support the use of this guidance.</p><p> </p><p>NCRAS is working closely with cancer charities to improve data collection and submission by hospital trusts, looking at how they can help improve completion rates and thus gain a better picture of the burden of recurrence and metastatic disease across the health service.</p><p> </p><p>To further support this work NCRAS has been sharing provider-level data on the completeness of recurrence reporting with individual NHS trusts since July 2016. These data are publicly available at the following link:</p><p> </p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 184979 question first answered 06/11/2018 15:35:08 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

997158

	registered interest
	date	29/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure hospital trusts meet the requirement to (a) collect and (b) submit data on secondary breast cancer.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	184979
	answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>140 hospital trusts submitted data for 2016 secondary breast cancer diagnoses through the Cancer Outcomes and Services Dataset or Cancer Waiting Times data collection mechanisms. The total number submitted was 11,608, which is an increase on 2014 and 2015. This is accepted as being significantly below the estimated number of secondary breast cancers.</p><p> </p><p>The National Cancer Registration and Analysis Service (NCRAS) has published a number of guidance documents including flowcharts and clearer data definitions, providing specific advice on how to record cancer patients who are on a non-primary pathway. NCRAS is visiting trusts to support the use of this guidance.</p><p> </p><p>NCRAS is working closely with cancer charities to improve data collection and submission by hospital trusts, looking at how they can help improve completion rates and thus gain a better picture of the burden of recurrence and metastatic disease across the health service.</p><p> </p><p>To further support this work NCRAS has been sharing provider-level data on the completeness of recurrence reporting with individual NHS trusts since July 2016. These data are publicly available at the following link:</p><p> </p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 184978 question first answered 06/11/2018 15:35:09 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

999363

	registered interest
	date	31/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what responsibility clinical commissioning groups have for funding family history clinics for people with a family history of breast cancer.
	tabling member constituency	Lincoln
	tabling member printed	Karen Lee
	uin	186437
	answer	answer is ministerial correction date of answer 09/11/2018 answer text <p>As set out in the Manual for Prescribed Specialised Services 2018/19, NHS England commissions inherited cancer services. This includes genetic testing for inherited cancer through the Genomic Laboratory Hubs and the genetic clinical service through the Regional Clinical Genetics Services.</p><p> </p><p>NHS England does not hold data on access to family history clinics for people with a family history of breast cancer across England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 186438 question first answered 09/11/2018 10:10:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4664 label Biography information for Karen Lee

999366

	registered interest
	date	31/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the accessibility of family history clinics for people with a family history of breast cancer across England.
	tabling member constituency	Lincoln
	tabling member printed	Karen Lee
	uin	186438
	answer	answer is ministerial correction date of answer 09/11/2018 answer text <p>As set out in the Manual for Prescribed Specialised Services 2018/19, NHS England commissions inherited cancer services. This includes genetic testing for inherited cancer through the Genomic Laboratory Hubs and the genetic clinical service through the Regional Clinical Genetics Services.</p><p> </p><p>NHS England does not hold data on access to family history clinics for people with a family history of breast cancer across England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 186437 question first answered 09/11/2018 10:10:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4664 label Biography information for Karen Lee

947427

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the levels of care and support available for women with breast cancer in (a) the West Midlands and (b) England.
	tabling member constituency	Birmingham, Northfield
	tabling member printed	Richard Burden
	uin	167862
	answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Birmingham and Solihull Clinical Commissioning Group, advises that breast cancer patients in Birmingham have support from a clinical nurse specialist and have a health needs assessment, which can refer patients for services including prosthesis fitting, wig referral, psychology service and lymphoedema service. In addition, there are several third sector organisations that provide a range of support to breast cancer patients across the area.</p><p> </p><p>NHS England is committed to transforming cancer care across England for all cancers, including breast cancer, aiming to reduce inequality and promoting equity of access to services. To support this ambition, NHS England has committed more than £200 million in 2017/18 and 2018/19 to fund Cancer Alliances to accelerate early diagnosis of cancer, improve survival and enhance quality of life.</p><p> </p><p>In February 2018, in partnership with the Department and NHS England, Public Health England (PHE) launched a Be Clear on Cancer Campaign focused on breast cancer in women aged over 70 to raise awareness of specific symptoms and encourage those with symptoms to visit their doctor.</p><p> </p><p>To improve the uptake of screening, NHS England is continuing to invest in initiatives to help ensure equality of access, including through locally targeted interventions. These include text and general practitioner reminders and PHE’s new ‘Breast screening: easy guide’, which helps women decide whether screening is right for them.</p><p> </p><p>NHS England agreed a Commercial Access Agreement with Roche for Kadcyla (trastuzumab emtansine) which brought the confidential purchase price below the National Institute for Health and Care Excellence cost-effectiveness threshold, allowing approval in routine commissioning. This is offering breast cancer patients precious quality time with their families without damaging side effects.</p><p> </p><p>Finally, we are committed to rolling out stratified follow-up pathways for breast cancer patients by 2020, to ensure patients get the right care after treatment, including information and support to spot signs and symptoms of recurrence or secondary cancer. As well as providing a better experience for patients and ensuring they have the information they need, stratified pathways can offer more effective use of resources by freeing up outpatient capacity. They can also ensure that in cases where there is recurrence or secondary cancer, patients are supported to return to care quickly and effectively.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:58:31 answering member 4067 label Biography information for Steve Brine
	tabling member	301 label Biography information for Richard Burden

983134

	registered interest
	date	08/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with Health Education England on training more breast radiologists and mammographers.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	176300
	answer	answer is ministerial correction date of answer 11/10/2018 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017, which commits to the expansion of capacity and skills including an ambition to increase improved working practices, attracting qualified people back to the National Health Service through domestic and international recruitment. This will include 668 more, full time equivalent, clinical radiologists and investing in 300 reporting radiographers by 2021 to support an increase in the capacity for earlier diagnosis.</p><p> </p><p>HEE intends to follow the plan later this year with a longer-term strategy that looks at the workforce needs beyond 2021. This will include exploring sustainable growth beyond 2021 in key professions through continued investment in training places, with a greater focus on attracting and retaining students and improving the numbers of qualified professionals who go on to work in the NHS.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/10/2018 16:42:09 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

946904

	registered interest
	date	23/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on the implementation of the Cancer Strategy in relation to breast cancer.
	tabling member constituency	Barnsley Central
	tabling member printed	Dan Jarvis
	uin	167281
	answer	answer is ministerial correction date of answer 04/09/2018 answer text <p>NHS England is committed to transforming cancer care across England for all cancers, including breast cancer, aiming to reduce inequality and promoting equity of access to services. To support this ambition, NHS England has committed more than £200 million in 2017/18 and 2018/19 to fund Cancer Alliances to accelerate early diagnosis of cancer, improve survival and enhance quality of life.</p><p> </p><p>In February 2018, in partnership with the Department and NHS England, Public Health England (PHE) launched a Be Clear on Cancer Campaign focused on Breast Cancer in women aged over 70 to raise awareness of specific symptoms and encourage those with symptoms to visit their doctor.</p><p> </p><p>To improve the uptake of screening, NHS England is continuing to invest in initiatives to help ensure equality of access, including through locally targeted interventions. These include text and general practitioner reminders and PHE’s new ‘Breast screening: easy guide’, which helps women decide whether screening is right for them.</p><p> </p><p>NHS England agreed a Commercial Access Agreement with Roche for Kadcyla (trastuzumab emtansine) which brought the confidential purchase price below the National Institute for Health and Care Excellence cost-effectiveness threshold, allowing approval in routine commissioning. This is offering breast cancer patients precious quality time with their families without damaging side effects.</p><p> </p><p>Finally, we are committed to rolling out stratified follow-up pathways for breast cancer patients by 2020, to ensure patients get the right care after treatment, including information and support to spot signs and symptoms of recurrence or secondary cancer. As well as providing a better experience for patients and ensuring they have the information they need, stratified pathways can offer more effective use of resources by freeing up outpatient capacity. They can also ensure that in cases where there is recurrence or secondary cancer, patients are supported to return to care quickly and effectively.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/09/2018 16:03:08 answering member 4067 label Biography information for Steve Brine
	tabling member	4243 label Biography information for Dan Jarvis

990404

	registered interest
	date	18/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what (a) financial support and (b) other resources his Department has provided to Cancer Alliances for long-term planning for breast cancer care.
	tabling member constituency	Newcastle upon Tyne North
	tabling member printed	Catherine McKinnell
	uin	181271
	answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>NHS England provides funding, support and guidance to Cancer Alliances to ensure the delivery of improvements in early and faster diagnosis and quality of life for people living with and beyond cancer, including breast cancer patients.</p><p>For this year, all Cancer Alliances have agreed plans in place for using transformation funding, focused on the delivery of NHS England’s 2018/19 Planning Guidance priorities. As part of these plans, Alliances will:</p><p>- progress towards the 2020/21 ambition for all breast cancer patients to move to a stratified follow-up pathway after treatment; and</p><p>- have in place clinically agreed protocols for stratifying breast cancer patients and a system for remote monitoring by the end of 2018/19.</p><p>In addition to transformation funding, support that all Cancer Alliances will receive in 2018/19 to transform care for their cancer patients includes:</p><p>- dedicated support from the National Cancer Programme’s analysis, evidence and data service;</p><p>- support and assurance from NHS England regional offices;</p><p>- a tailored programme of leadership development; and</p><p>- a series of national events to share best practice and information across Cancer Alliances.</p><p>More information about the levels of transformation funding received by each Cancer Alliance in 2018/19, and how they are using this to improve cancer care, can be found on NHS England’s website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/cancer/improve/cancer-alliances-improving-care-locally/nhs-england-support-and-funding-for-cancer-alliances/" target="_blank">https://www.england.nhs.uk/cancer/improve/cancer-alliances-improving-care-locally/nhs-england-support-and-funding-for-cancer-alliances/</a></p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:45:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4125 label Biography information for Catherine McKinnell

933856

	registered interest
	date	02/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the DNA test for breast cancer assessment will be available on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	159604
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>Some forms of DNA testing for cancer are available on the National Health Service. For example, the BRCA1 and BRCA2 genes raise the risk of cancer if they become altered. Having a variant BRCA gene greatly increases a woman's chance of developing breast cancer and ovarian cancer. The National Institute for Health and Care Excellence guidelines require that people with a 10% or higher risk of carrying BRCA genes are able to be counselled, supported and tested.</p><p> </p><p>However, many other DNA tests for breast cancer are still in the research phase, and are therefore not routinely available.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/07/2018 15:39:50 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

1063828

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the statement on page 72 of the Independent Cancer Taskforce's Cancer Strategy for 2015-2020 that all NHS trusts should now be recording recurrent and secondary breast cancer patients, how many and what proportion of NHS trusts are undertaking such recording.
	tabling member constituency	Oldham East and Saddleworth
	tabling member printed	Debbie Abrahams
	uin	222763
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. Health Education England is also working to expand the number of CNS and develop clear CNS competencies and routes into training.</p><p>The National Cancer Registration and Analysis Service (NCRAS) has mandated collection of breast cancer recurrence data in its Cancer Services and Outcomes Dataset (COSD) since 2013. Hospital trusts are also required to submit recurrence data in the Cancer Waiting Times (CWT) dataset. Data published on the NCRAS legacy website shows that of the 140 trusts that could be expected to be collecting data on breast cancer recurrence in 2016, 140 submitted data for 2016 diagnoses through the COSD or CWT data collection mechanisms. The NCRAS legacy website is available at the following link:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222762 question first answered 21/02/2019 14:58:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4212 label Biography information for Debbie Abrahams